Spears Abacus Advisors LLC Bristol Myers Squibb CO Transaction History

Spears Abacus Advisors LLC

  • $4.73 Billion
  • Q3 2024

A detailed history of Spears Abacus Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Spears Abacus Advisors LLC holds 273,382 shares of BMY stock, worth $15.8 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
273,382
Previous 270,684 1.0%
Holding current value
$15.8 Million
Previous $11.2 Million 25.85%
% of portfolio
0.3%
Previous 0.24%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$39.66 - $51.75 $107,002 - $139,621
2,698 Added 1.0%
273,382 $14.1 Million
Q2 2024

Aug 12, 2024
SELL
$40.25 - $52.99 $784,311 - $1.03 Million
-19,486 Reduced 6.72%
270,684 $11.2 Million
Q1 2024

May 10, 2024
BUY
$47.98 - $54.4 $13.3 Million - $15.1 Million
276,996 Added 2102.6%
290,170 $15.7 Million
Q1 2023

May 15, 2023
BUY
$65.71 - $74.53 $22,604 - $25,638
344 Added 2.68%
13,174 $913,000
Q4 2022

Feb 13, 2023
BUY
$68.48 - $81.09 $17,120 - $20,272
250 Added 1.99%
12,830 $922,000
Q3 2022

Nov 14, 2022
SELL
$0.13 - $76.84 $8 - $5,225
-68 Reduced 0.54%
12,580 $894,000
Q2 2022

Aug 08, 2022
SELL
$72.62 - $79.98 $20,696 - $22,794
-285 Reduced 2.2%
12,648 $974,000
Q1 2022

May 13, 2022
SELL
$61.48 - $73.72 $12,296 - $14,744
-200 Reduced 1.52%
12,933 $944,000
Q4 2021

Feb 14, 2022
BUY
$53.63 - $62.52 $15,284 - $17,818
285 Added 2.22%
13,133 $819,000
Q2 2021

Aug 09, 2021
BUY
$61.91 - $67.42 $185,730 - $202,260
3,000 Added 30.46%
12,848 $859,000
Q1 2021

May 14, 2021
SELL
$59.34 - $66.74 $9,197 - $10,344
-155 Reduced 1.55%
9,848 $622,000
Q2 2020

Aug 12, 2020
SELL
$54.82 - $64.09 $13,924 - $16,278
-254 Reduced 2.48%
10,003 $588,000
Q1 2020

May 15, 2020
SELL
$46.4 - $67.43 $56,051 - $81,455
-1,208 Reduced 10.54%
10,257 $572,000
Q4 2019

Feb 14, 2020
BUY
$49.21 - $64.19 $89,808 - $117,146
1,825 Added 18.93%
11,465 $736,000
Q2 2019

Aug 09, 2019
BUY
$44.62 - $49.34 $13,386 - $14,802
300 Added 3.21%
9,640 $437,000
Q2 2018

Aug 10, 2018
SELL
$50.53 - $62.98 $379,328 - $472,790
-7,507 Reduced 44.56%
9,340 $517,000
Q1 2018

May 15, 2018
SELL
$59.92 - $68.98 $208,701 - $240,257
-3,483 Reduced 17.13%
16,847 $1.07 Million
Q4 2017

Feb 14, 2018
BUY
$59.94 - $65.35 $359,640 - $392,099
6,000 Added 41.87%
20,330 $1.25 Million
Q2 2017

Aug 11, 2017
BUY
N/A
14,330
14,330 $798,000

Others Institutions Holding BMY

# of Institutions
2,532
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Spears Abacus Advisors LLC Portfolio

Follow Spears Abacus Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spears Abacus Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spears Abacus Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email